CLDN18.2/CD19 targeted CAR-T / Innovative Cellular Therapeutics  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
CLDN18.2/CD19 targeted CAR-T / Innovative Cellular Therapeutics
ChiCTR1900022619: (CLDN18.2+CD19) targeted Chimeric Antigen Receptor T Cells (CART) Therapy for gastric cancer

Not yet recruiting
1
6
 
(CLDN18.2+CD19) targeted Chimeric Antigen Receptor T Cells (CART) Therapy
The Fifth Hospital Affiliated to Zhongshan University; The Fifth Hospital Affiliated to Zhongshan University, Innovative Cellular Therapeutics Co.,Ltd.
gastric cancer
 
 

Download Options